ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Internal Medicine

Top Internal Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DANIEL CASPER MD

Internal Medicine

21,915

$1.53M

877
745 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $58

JERZY MAGDA MD

Internal Medicine

21,852

$1.28M

925
776 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $58

BASIL JAWAD MD

Internal Medicine

21,829

$936K

528
446 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $58

ANNE HAYES M.D.

Internal Medicine

21,727

$1.28M

716
640 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

WON KIM M.D.

Internal Medicine

21,655

$1.14M

735
659 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

2%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $58

WLADYSLAW BOBAK MD

Internal Medicine

21,653

$1.08M

687
416 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $58

GUY FASCIANA M.D.

Internal Medicine

21,456

$1.13M

545
410 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $58

THOMAS MINORA M.D.

Internal Medicine

21,438

$966K

650
568 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $58

GREGORY AMBUSKE D.O.

Internal Medicine

21,258

$1.2M

621
543 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

HALLIE BEYER M.D.

Internal Medicine

21,022

$1.05M

437
391 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $58

RAJAN MULLOTH MD

Internal Medicine

20,846

$1M

537
412 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $58

PAVEL PRIBULA M.D.

Internal Medicine

20,830

$940K

566
503 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $58

GEORGE PUEBLITZ MD

Internal Medicine

20,787

$996K

611
480 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $58

ZOYA BERENSON MD

Internal Medicine

20,778

$1.56M

277
251 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $58

KAMRAN SALEH M.D.

Internal Medicine

20,639

$1.06M

634
517 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $58

GEORGE HEFFNER MD

Internal Medicine

20,587

$986K

802
658 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $58

TERENCE PHILBIN M.D.

Internal Medicine

20,442

$1.17M

833
720 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

HENRY FOLB M.D.

Internal Medicine

20,313

$909K

617
494 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $58

KAREN NICHOLS MD

Internal Medicine

20,218

$283

354
323 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$0
Average prescription price

Avg: $58

DAN BUTOI M.D.

Internal Medicine

20,201

$1.09M

396
313 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

CHRISTOPHER HESTER M.D.

Internal Medicine

20,192

$1.04M

609
524 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

BHARAT MEHTA MD

Internal Medicine

20,165

$1.27M

438
371 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $58

STEPHEN SHOEMAKER D.O.

Internal Medicine

20,140

$1.15M

548
467 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

ANIL PRABHU M.D.

Internal Medicine

20,133

$892K

497
488 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

LEONARD KUCHEMBA M.D.

Internal Medicine

20,132

$1.32M

466
380 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank